New search | Conferencedetail
mail
Print view
 
 

6th Obesity and NASH Drug Development Summit 2022

Evvnt Promotion / evvnt
-
29.11.2022 - 01.12.2022  Revere Hotel Boston Common, 200 Stuart Street, 02116 Boston, Massachusetts, USA
Time: 09:55 - 16:40
 
Conference themes
The first wave of investment in NASH is dispersing in the wake of highly demanding biopsy endpoints, but opportunities to target obesity and metabolic syndrome are catalyzing increasing excitement. Pivotal readouts in GLP-1 receptor agonists and exciting progress in regenerative medicine and microRNAs are redefining the drug development landscape for metabolic disorders.
Professional congress organizer (PCO)
Hanson Wade
Notes
Brochure: https://go.evvnt.com/1277295-3?pid=4832

Speakers: Allison Goldfine, Director, Translational Medicine Cardiometabolic Disease, Novartis, Andrew Billin, Senior Director Biomarker Sciences, Gilead, and more.
 

Enquiries and Registration:

https://go.evvnt.com/1277295-2?pid=4832
Ms. Jessica Durston
 
Categories
General Medicine
Languages
English
Congress fees
USD 2599.00 - USD 5097.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Center of ExcellenceCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioEuropean Public Health Association (EUPHA)Ärztekammer für WiennewTreeAnästhesie in Entwicklungsländern e. V.Alumni Club Medizinische Universität Wien